In prostate tumour tissues, a WDFY2 down-regulation has been highlighted and correlated with advanced stage, increased metastasis and poor prognosis in patients, being AKT signalling modulation the mechanism adopted by WDFY2 protein to inhibit cancer progression and metastasis [62]. This evidence concerns the gene AKT1 and prostate neoplasm.